Works matching IS 17562856 AND DT 2010 AND VI 3 AND IP 5
Results: 6
Anti-aquaporin-4 antibodies in Devic’s neuromyelitis optica: therapeutic implications.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 5, p. 311, doi. 10.1177/1756285610382478
- By:
- Publication type:
- Article
An update on the treatment of Sydenham’s chorea: the evidence for established and evolving interventions.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 5, p. 301, doi. 10.1177/1756285610382063
- By:
- Publication type:
- Article
Natalizumab in pediatric multiple sclerosis patients.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 5, p. 293, doi. 10.1177/1756285610381526
- By:
- Publication type:
- Article
Acute stroke and cytomegalovirus encephalitis: a coincidence?
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 5, p. 323, doi. 10.1177/1756285610380491
- By:
- Publication type:
- Article
Chemotherapeutics in the treatment of multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 5, p. 277, doi. 10.1177/1756285610379885
- By:
- Publication type:
- Article
The use of gabapentin enacarbil in the treatment of restless legs syndrome.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 5, p. 269, doi. 10.1177/1756285610378059
- By:
- Publication type:
- Article